.svg)
Why CRO Pathology is Not Enough for Biomarker-Driven Trials
The gap is structural, not a question of lab quality. See what CROs do well, where the model breaks down, and how Diagnexia Analytix fits alongside.
Compare at a glance
CRO Pathology vs Diagnexia Analytix
at a glance
Fair comparison. CROs stay essential for lab and logistics; Diagnexia Analytix augments where the model falls short.
Workflow
How Diagnexia Analytix Fits in Your Workflow
From sample to trial decision. CROs or Diagnexia Analytix can execute wet lab; CROs also run NGS, spatial, and expanded assays. Diagnexia Analytix does not replace these groups. It acts as the pathology decision and interpretation layer.
Sample to lab
- Defined turnaround processes
- Either can execute
Assay execution
- Processing, H&E, IHC, staining, slide prep
- Either can execute; DAX does not replace CRO
- NGS, spatial biology, expanded assays
- CROs run these; DAX does not replace
Data generation
- Raw data and structured outputs from assays above
- Feeds into interpretation layer
Tissue-anchored interpretation
- Expert and subspecialist pathology review
- Quantitative, reproducible scoring
- Interpretation of tissue data for trial decisions
Decision gate
Diagnexia Analytix is required: expert pathology interpretation to apply eligibility criteria consistently (e.g. histology, grade, biomarker eligibility).
Decision gate
Diagnexia Analytix is required: quantitative pathology and threshold validation so biomarker calls are reproducible and trial-ready.
Decision gate
Diagnexia Analytix is required: pathology endpoint adjudication and consistency so efficacy readouts are defensible.
Trial decision support
- Strategic pathology input for trial decisions
- Integration of tissue and biomarker evidence
CROs and Diagnexia Analytix can both run wet lab and logistics; CROs also run NGS and spatial platforms. Diagnexia Analytix does not replace those groups. It sits as the pathology decision and interpretation layer so that inclusion, thresholds, endpoints, and go/no-go are informed by expert, reproducible tissue interpretation.
CRO Does Well
What CRO Pathology Does Well
Central lab pathology is the backbone of trial execution. These strengths are real and respected.
Central lab & logistics
- Centralised processing, staining (H&E, IHC)
- Defined turnaround processes
- Multi-site, global sample handling
Compliance & quality
- Accredited labs (CLIA/CAP, ISO 15189)
- Validated assays, GCP data management
- Chain-of-custody, audit trails
Scale & documentation
- Large sample volumes
- Standardised documentation
- Structured data for trial DB
CRO Breaks Down
Where the CRO Model Breaks Down
Structural limits, not negligence. For biomarker-driven programmes these gaps create real risk.
Digital-first workflow
- Niche expertise hard to scale
- Generalists or ad hoc subcontracting
- Delay and inconsistency when it matters
Manual / semi-quantitative scoring
- IHC and biomarkers scored by eye
- Inter-reader and inter-site variability
- Quantitative, locked scoring rare at scale
Variability across phases
- Different labs per study or phase
- Assay handover breaks continuity
- Batch effects, protocol drift
Transactional, not strategic
- Deliverables-focused contracts
- Pathology seldom in trial design
- Insights that could de-risk stay in the silo
Built Differently
How Diagnexia Analytix is
Built Differently
Diagnexia Analytix is not a CRO. It is a network-led, digital-first expert pathology partner that fills these gaps.
Global subspecialist network
- Right expert per disease or tissue type
- On-demand subspecialist access at scale
Digital-first workflow
- Whole slide imaging, remote review
- Faster turnaround, distributed capacity
- On-demand subspecialist access at scale
Continuity across phases
- Translational through to late-stage
- Same leadership and definitions
- Strategic input, not just reads
Quantitative, reproducible outputs
- Standardised biomarker scoring
- Image analysis and validated methods
- Consistency across samples and time
Why Choose Us
A Scalable, Expert-Driven Pathology Partner for Your Research Success
.svg)
Speed to Data
Accelerate decision-making with rapid expert review and high-throughput digital workflows that reduce turnaround times at every stage.
Global Expert Access
Tap into a world-class network of sub-specialty pathologists, available on demand to support complex and high-volume studies.
Reproducible Results
AI-powered quality control and centralised protocols ensure consistency, reducing variability across sites, timepoints and geographies.
.svg)
Scalable by Design
Expand or reduce support as needed. Our infrastructure flexes with your study size, timelines and therapeutic focus.
Strategic Partnership
More than a vendor, we act as an embedded pathology function, supporting biomarker discovery, regulatory readiness and trial optimisation.
Talk to our
Pathology Team
CRO pathology alone often isn’t enough for complex biomarker programmes. Diagnexia Analytix is built to close the gap and de-risk pathology alongside your existing partners.
